Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
The Global Psoriasis Market Report by The Business Research Company covers psoriasis market drivers and restraints, psoriasis market size, major players, and the impact of COVID-19 on the psoriasis market.
The psoriasis drugs market consists of sales of psoriasis drugs. Psoriasis is a persistent skin disorder which causes distress and pain through patches of abnormal skin. Psoriasis can be caused due to injuries to skin, medications, genetics, infection, diet, weather, etc. The drugs vary depending on the severity of the infection and provide relief from infections. Examples of drugs in the psoriasis market include clobetasol (Temovate), triamcinolone (Aristocort), fluocinolone (Synalar), and betamethasone (Diprolene).
The rise in the prevalence of psoriasis patients is driving the Psoriasis market. Psoriasis is caused due to immune system, genetics and environment.
The global psoriasis market is expected to grow from $15.06 billion in 2020 to $15.86 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $21.97 billion in 2025 at a CAGR of 8.5%.
Request A Sample For The Global Psoriasis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp
Some psoriasis market trends include combination therapy. Combination therapy is an f treatment that combines two different psoriasis treatments at the same time. When two drugs with different mechanisms of action are combined (combination therapy), the effect is greater than that obtained by monotherapy (treatment with a single drug). Studies suggest that combination therapy eases psoriasis symptoms more effectively than a single therapy and has lesser side effects.
Global psoriasis market segments include:
1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor.
2) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce.
3) By Drug Types: Small Molecules, Biologics.
4) By Route Of Administration: Oral, Tropical, Injectable.
5) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Psoriasis Global Market Report 2021: COVID 19 Impact and Recovery to 2030 At:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
The Psoriasis Global Market Report 2021: COVID 19 Impact and Recovery to 2030 is one of a series of new reports from The Business Research Company that provides psoriasis market overviews, analyzes and forecasts market size, share, psoriasis market players, psoriasis market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The psoriasis market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Psoriasis Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.
Market Players Covered: AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company., Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co, Inc., Janssen Biotech, Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca, UCB, Sun Pharmaceutical Industries Ltd, Forward Pharma, Almirall, Valeant Pharmaceuticals, Biogen Idec, Biocon, Celltrion Inc., Dr.Reddy’s Laboratories.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The psoriasis Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The psoriasis Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Psoriasis Global Market Report 2021:
